More than half of individuals experiencing major thermal burn injury (MThBI) receive an autologous skin graft (autograft), in which skin is removed from a healthy "donor" site and transplanted to the burn site. Persistent pain and itch at the graft site are major causes of suffering and disability in MThBI survivors. African Americans have a higher risk of MThBI, and in other clinical settings African Americans experience a greater burden of pain and itch relative to European Americans. However, to our knowledge, ethnic differences in skin graft site pain and itch outcomes after MThBI have not been assessed. We evaluated skin graft site pain and itch severity (0-10 Numeric Rating Scale [NRS]) over 1 year in a prospective multicenter cohort sample of African Americans and European Americans. In adjusted linear mixed models, African Americans experienced a slower rate of pain resolution in the acute phase of recovery (b 5 20.05 vs 20.08 NRS points per day, P , 0.001), which resulted in a higher pain severity in the persistent phase of recovery (NRS mean difference 5 1.21, 95% confidence interval [0.12-2.29]), although not statistically significant after correction for multiple comparisons. African Americans also experience greater itch severity in 6 weeks to 12 months after burn injury compared with European Americans (NRS mean difference 5 1.86 [0.80-2.93]), which results from a faster rate of itch development in African Americans in the acute recovery phase after burn injury. Future studies may improve outcomes in African Americans and lead to new pathogenic insights that benefit all burn injury survivors.
Introduction
Burn injuries affect 11 million people annually worldwide. 45 In the United States, over 700,000 patients seek care for burn injuries each year and more than 50,000 are hospitalized for major burn injury. 33 More than half of these individuals receive an autologous skin graft (autograft), in which skin is removed from a healthy "donor" site and transplanted to the burn site. 9, 28, 53 Among major thermal burn injury (MThBI) survivors who receive tissue autograft, pain and itch at the autograft site are common and highly morbid. 10, 12, 44, 58 Based on the National Burn Registry and the US Census data, African Americans are 1.5 times as likely to experience burn injury compared with European Americans, 2, 8 and in other clinical settings African Americans have been shown to experience a greater burden of pain and itch relative to European Americans. 14, 17, 50, 56 Some of this disparity in pain and itch outcomes is likely due to the markedly greater socioeconomic disadvantage experienced by African Americans 25, 41, 64 ; however, evidence from other health conditions characterized by chronic pain or itch suggests that differences in health outcomes between African Americans and European Americans may not be due to socioeconomic differences alone. 46, 52, 56, 64 To our knowledge, pain and itch outcomes in African American vs European American survivors of MThBI have not previously been compared. In this study, we evaluated pain and itch outcomes from the time of hospitalization through 1 year in these 2 groups. We hypothesized that acute and chronic pain and itch at the site of tissue autograft would be more common in African Americans, even after adjusting for socioeconomic status. In addition, we hypothesized that these differences would not be due to ethnic differences 13, 23, 42 in receipt of opioid medications.
Methods

Design, setting, and participant eligibility criteria
European American and African American patients undergoing tissue autograft after MThBI between February 2012 and June 2015 at 1 of 3 burn centers (University of North Carolina, Chapel
Hill, NC; MedStar Washington Hospital Center, Washington, DC, and University of South Florida, Tampa, FL) were enrolled. We assessed ethnicity by self-report during screening, and again during abstraction of the medical record at the time of admission and exclusively enrolled European Americans and African Americans. Exclusion criteria included age ,18 or .65; admission .72 hours after MThBI; estimated total body surface area (TBSA) burn .30%; intentional, electrical, or a chemical mechanism; autograft performed .14 days after admission to burn center or autograft decision made .7 days after admission, Childs-Pugh liver failure stage B or C, burn that required escharotomy; end-stage renal disease; chronic opioid use .20 morphine equivalents per day before burn; preburn skin disorder causing pruritus; substantial comorbid traumatic injury; pregnancy or breastfeeding; and residing more than 100 miles from enrollment site. In addition, individuals unwilling to provide a blood sample, prisoners, suicidal, homicidal, or psychotic individuals, and individuals who did not read and speak English were excluded. There was no patient in the sample who self-reported a mast cell disorder. Individuals with ,30% TBSA burn were enrolled because such individuals constitute the majority of burns that present to a burn center 2 and are able to provide pain scores (eg, are not intubated). Other exclusion criteria were chosen to remove heterogeneous populations (eg, children, electrical burns, and individuals presenting long after injury). Participants were compensated $70, $50, $30, and $70 for completion of the initial, 6 week, 6 month, and 1 year assessments, respectively.
Study procedures
The institutional review board at each burn center approved the study protocol and each participant provided written informed consent. Enrollment flowchart is shown in Figure 1 . Retaining a low percentage of screened patients in a study is common among trauma populations, including previously collected cohorts in motor vehicle collision, 29 critical illness, 43 burn injury, 15, 59 and traumatic brain injury. 57 Of our sample who were approached, 21% refused enrollment, which is consistent with other studies in burn injury. 22, 24 The most common reasons participants were excluded from the study was being ,18 or .59 years of age (20%), delayed presentation for treatment (10%), burn not severe enough to require tissue autograft (16%), nonthermal burn (12%), and reside more than 100 miles from burn center (10%). Structured in-person interviews were conducted by research assistants at the time of enrollment. Follow-up interviews were conducted daily through day 7, weekly through day 21, at 6 weeks, and then monthly thereafter. Data regarding burn injury characteristics, including estimated burn TBSA and mechanism, were extracted from the medical record.
Measures
Pain assessments
Verbal rating scales are strongly correlated with visual analogue scales 20, 27, 40 and are optimal in populations with injuries that may impair arm or hand use. A 0 to 10 verbal Numeric Rating Scale (NRS) score was used to assess the severity of both graft site pain and graft site itch during the past 24 hours. 3 Specifically, patients were asked on enrollment "on a scale of 0 to 10, where "0" means no pain or itch and "10" means pain or itch as severe as it could possibly be, what was the usual intensity of your pain or itch during the past 24 hours, considering any or all of your burn pain or itch together?" Daily inpatient or outpatient follow-up patients were asked, "on a scale of 0 to 10, where "0" means no pain or itch and "10" means pain or itch as severe as it could possibly be, what was the usual intensity of your pain or itch during the past 24 hours, considering only the pain or itch from your graft site?" Monthly follow-up patients were asked, "on a scale of 0 to 10, where "0" means no pain or itch and "10" means pain or itch as severe as it could possibly be, what was the usual intensity of your pain or itch during the past week, considering only the pain or itch from your graft site?" Initial survey and inpatient follow-up over the first 3 weeks after burn injury occurred through in-person interviews, whereas outpatient follow-up occurred through structured telephone interview. Pain and itch severity were assessed daily for the first 7 days after injury, at weeks 2, 3, and 4, and then monthly during months 3 through 12. An NRS score of $ 4 was used to define moderate or severe symptom severity. A change in NRS of 15% has been associated with a clinically meaningful difference in pain experience. 51 
General health status before burn injury
The SF-12 was administered at the time of enrollment to assess general mental health (Mental Component Score, MCS) and general physical health (Physical Component Score, PCS) during the month before burn injury. 61 Higher scores on these scales correspond to better health status. 61 
Posttraumatic stress disorder symptom severity
Posttraumatic stress disorder (PTSD) symptom severity in the immediate aftermath of burn injury was assessed using the PTSD Symptom Scale-Interview (PSSI). 19 
Depression and anxiety assessment
Depression and anxiety severity was assessed over the week before burn injury with subscales of the Depression, Anxiety, and Stress Scale (DASS)-21 35, 36 The DASS-21 has been previously validated in survivors of trauma. 65 
Pain catastrophizing assessment
The Pain Catastrophizing Scale (PCS) was used to assess the influence of catastrophizing on pain severity in the immediate aftermath of burn injury at the time of study enrollment. 55 The PCS is a validated, 13-item assessment that measures the tendency for catastrophizing ideation in pain experiences. 55 This scale has previously been used and validated in populations of trauma survivors. 30 
Assessment of analgesic medication usage
Information regarding inpatient medications received was extracted from the medical record. At each follow-up assessment, participants were asked about use (yes/no) of medication in the previous week, including medications that were taken "over the counter" and medications that were prescribed. Two licensed physicians independently categorized the medication by class, differences were adjudicated, and these data were recorded in binary variables for analysis.
Statistical analyses
Student t test was used to assess significance of the differences in continuous independent variables, and x 2 tests were used to Mixed models (as implemented in PROC MIXED, SAS 9.4, SAS Institute Inc., Cary, NC) were used to model repeated pain or itch outcome measures (0-10 NRS). Each model contained a binary indicator variable for race and a continuous variable denoting the number of days since trauma, as well as the interaction between time since burn injury and ethnicity. Correlations between measurements within each subject were taken into account by specifying an unstructured covariance matrix for model residuals.
A piecewise mixed linear model with random slopes and intercepts and a node at 6 weeks was used to model the biphasic nature of the acute vs persistent changes in pain and itch severity. Random slopes and intercepts were allowed to correlate in these models. Each model was adjusted for patient age, sex, percent TBSA and ranks for patient education, income, and type of burn injury categories. Given that the difference in acute pain, acute itch, persistent pain, and persistent itch (4 outcomes) were examined, P value of 0.0125 was considered statistically significant. Six patient characteristics at baseline were examined (SF-12 MCS, SF-12 PCS, PTSD severity score, depression scale, and anxiety scale), and therefore, a P value , 0.008 was considered significant. P values were reported for testing the null hypothesis that no differences exist in mean outcomes between the 2 race groups.
Results
Participants
Demographic characteristics and follow-up
Participant characteristics are presented in Table 1 . Most study participants (n 5 96) were men younger than 40 years with some education post high school. Nearly half were African American (48%, 46/96). The proportion of men and mean age of European Americans and African Americans were very similar; a greater proportion of European American participants earned more than $60,000 annually. Overall follow-up was 90/96 (94%) participants at 6 weeks, 77/96 (80%) at 3 months, 82/96 (85%) at 6 months, and 77/96 (80%) at 12 months; similar follow-up rates were observed between European American and African American 
Burn characteristics
The majority of enrolled participants had a burn that was ,10% of their TBSA, with approximately 3% TBSA affected by a fullthickness injury. Almost three-quarters of patients sustained a burn in only 1 anatomical region (68/95, 72%). The most common locations of burn injury were the upper extremity (72/95, 76%) followed by lower extremities (33/95, 35%) . Approximately half of burn injuries were due to flame and half were due to scald.
Reported preburn health status and peritraumatic symptoms
Reported preburn physical health was similar in the 2 groups ( Table 2) . African Americans reported better preburn mental health than European Americans; however, after adjusting for multiple comparisons, this result did not reach statistical significance based on Bonferroni corrected P value. There were no significant differences reported in preburn depressive or anxiety symptoms between groups ( Table 2) , and there was no difference in peritraumatic pain catastrophizing between European American and African American patients.
Burn autograft pain resolution in African Americans vs European Americans experiencing major thermal burn injury
In an initial linear mixed model, a significant interaction was observed between ethnicity and time since burn injury (b 5 0.004, P 5 0.04, supplemental Tables 1 and 2 ; available online at http://links.lww.com/PAIN/A472). Therefore, a linear mixed model was fit in which acute pain (#6 weeks, corresponding to the inflammatory and proliferative phase of wound healing 11, 54 ) and persistent pain (.6 weeks, corresponding to the maturation phase of wound healing 11, 18 ) were represented by separate linear components conjoined at a node 6 weeks after injury ( Fig. 2A) .
During the 6 weeks after MThBI, European American burn survivors' pain resolved at a faster rate (NRS points per day) than African Americans (b 5 20.08 vs 20.05, P , 0.001, Table 3 ). Thereafter, the rate of pain resolution between European American and African American participants was similar (difference in slope 5 0.001, P 5 0.60, Table 3 ). Because of their reduced early recovery and similar subsequent recovery rate, African Americans had a trend towards higher pain severity than European Americans from 6 weeks through 1 year (NRS mean difference 5 1.21, P 5 0.03). This result did not change substantially when itch was included as a covariate (data not shown).
Pain and itch are significantly correlated in both European Americans and African Americans at month 6 and month 12 after MThBI (supplemental Table 3 ; available online at http://links.lww. com/PAIN/A472); however at week 6, pain and itch were correlated in European Americans but not African Americans (r 5 0.32, P 5 0.028 in European Americans and r 5 0.23, P 5 0.140 in African Americans).
Burn autograft itch resolution in African Americans vs European Americans experiencing major thermal burn injury
As with burn autograft pain, in an initial mixed linear model, a significant interaction was observed between ethnicity and time since burn injury (b 5 0.007, P 5 0.03, supplemental Tables 4 and 5 ; available online at http://links.lww.com/PAIN/A472). A linear mixed model was therefore fit in which acute and persistent itch were represented by separate linear components, according to the wound healing phases described above (Fig. 2B) . Although European Americans experienced stable itch intensity during the first 6 weeks after burn injury (b 5 20.003, P 5 0.66, Table 3 ), African Americans experienced progressively increasing itch severity during this time (b 5 0.05, P 5 ,0.001, Table 3 ). After 6 weeks, itch , a P , 0.008 was considered statistically significant. * SF-12 assessed general health over the month before MThBI, DASS assessed symptoms of depression and anxiety over the week before MThBI. † Pain catastrophizing was assessed at the time of study enrollment in the immediate aftermath of MThBI; PSSI was assessed at the time of study enrollment measuring PTSD symptoms in the early aftermath of MThBI. DASS, Depression Anxiety Stress Scale; MThBI, major thermal burn injury; PTSD, posttraumatic stress disorder; PSSI, PTSD Symptom Scale-Interview. intensity decreased among European Americans and African Americans at a similar rate. Because of their much higher average itch severity at 6 weeks and a similar rate of itch recovery after 6 weeks, African Americans experienced more severe persistent itch symptoms than European Americans (average severity almost 2 points higher on a 0-10 NRS, P 5 ,0.001).
Moderate or severe burn autograft pain outcomes in African Americans and European Americans
In addition to evaluating pain as a continuous outcome, we also compared the proportion of African American and European American participants with moderate or severe pain at each follow-up time point (Fig. 3) . Approximately 90% of African American and European American participants experienced moderate or severe acute pain. Differences in the proportion of African American vs European American with moderate or severe pain generally increased after the 6-week time point, but at no time did the difference in the proportion of African American vs European American participants with moderate or severe pain meet statistical significance.
Moderate or severe autograft itch outcomes in African Americans and European Americans
In addition to evaluating itch as a continuous outcome, we also compared the proportion of African American and European American MThBI survivors with moderate or severe itch at each follow-up time point (Fig. 4) . Approximately 20% to 30% of African American and European American MThBI survivors experienced moderate or severe acute itch, and the prevalence of moderate or severe itch in these groups gradually increased in the initial weeks after MThBI. Differences in point prevalence of moderate or severe itch between African Americans and European Americans were most pronounced at week 6 (Fig. 4) . The proportion of African American participants with moderate or severe itch was significantly higher than European Americans at month 6 (P 5 0.02), month 9 (0.0004), and month 12 (P 5 0.02) Effect estimates from multivariate piecewise linear mixed model of graft site pain and itch after major thermal burn injury. ( Fig. 4) and at month 4 (P 5 0.03), month 5 (P 5 0.02), month 7 (P 5 0.0007), 8 (P 5 0.0004), month 10 (P 5 0.0001), and month 11 (P 5 0.002) (data not shown).
Analgesic consumption by drug class and ethnicity after discharge from burn center
Opioid analgesic use (yes/no) did not differ significantly between European American and African Americans at the time of discharge (P 5 0.5) and was very similar in the 2 groups across medication class and time points (Table 4) . For example, 76% of both European Americans and African Americans were prescribed opioids on discharge from the burn unit. Although a significantly higher proportion of European Americans were taking acetaminophen at the month 6 time point (19% vs 2%, P 5 0.01), there were overall no other statistically significant differences between ethnicities across other medication classes including anticonvulsants, antidepressants, nonsteroidal anti-inflammatory drugs, and acetaminophen at other time points.
Discussion
Moderate or severe pain and itch are common, morbid sequelae of MThBI that result in substantial losses in mental and physical health. 39 Results of this prospective multicenter study suggest that African American survivors of MThBI experience a more gradual reduction in pain during the initial 6 weeks after injury vs European Americans, resulting in a trend towards more severe persistent pain in the year after MThBI. In addition, because African American survivors of MThBI experience a progressive increase in itch severity during the initial 6 weeks after injury, African American MThBI survivors experienced a greater severity of chronic itch over time. These differences were not due to ethnic differences in use of an opioid (yes or no) or to differences in age, sex, education, TBSA, type of burn, or income. Although European Americans had lower aggregate mental health functioning (assessed via the SF-12) before MThBI, adjusting for this did not significantly influence the results that African Americans experience greater pain and itch severity after MThBI. These study results are important, given that African Americans are at 50% higher risk of sustaining a burn injury based on estimated from the National Burn Registry and US Census data. 2, 8 Previous studies have shown that mental health characteristics predict poor pain and itch outcomes after injury; 1,5,21,58 thus, we explored whether ethnic differences in baseline mental health might account for worse pain and itch outcomes in African Americans in the present study. Among the 6 pre-and periburn mental health characteristics evaluated, function or symptom www.painjournalonline.com 2273 levels were similar, with the exception of SF-12 Mental Component Score, which had trend-level significance at our multiple testing-adjusted significance threshold. However, despite this, African Americans continued to experience significantly worse itch outcomes and a greater proportion of African Americans experience persistent moderate or severe pain after MThBI. Previous studies have found that African Americans are sometimes prescribed fewer opioid analgesics than European Americans; 13, 42, 47 thus, we explored whether ethnic differences in receipt of opioid analgesics might account for worse pain and itch outcomes in African Americans in the present study. However, no significant differences in the proportion of European American vs African American MThBI survivors receiving opioid prescriptions were observed, and the proportion of participants taking common adjunctive medications in the 2 groups was very similar. Based on these data, observed ethnic differences are not likely related to differences in receipt of an opioid prescription. Acetaminophen was more likely to be used/self-reported by European Americans 6 months after MThBI. We believe that this difference at 6 months is unlikely to be driving the difference seen in pain outcomes between ethnicities, for the following reasons: (1) adjusting for whether patients were taking acetaminophen at 6 months did not reduce differences in chronic pain/itch between ethnicities; (2) pain outcomes were assessed using data from 20 time points, and analgesic differences were only reported at one of these time points (6 months); and (3) acetaminophen is a weak analgesic and has not shown efficacy to treat chronic pain (eg, osteoarthritis and spine pain 31, 37 ). Of note, 75% (53/71) of study participants received opioids without any other adjunctive analgesic medications. Multimodal analgesia has been shown to reduce opioid use and improve pain and functional outcomes in other settings 6, 16 and has been advocated for MThBI survivors. 49 Further studies are needed to evaluate the utility of multimodal analgesia and identify novel nonopioid treatment options for MThBI survivors experiencing moderate or severe pain.
To our knowledge, this is the first study to evaluate acute and chronic pain and itch outcomes in African Americans vs European Americans experiencing MThBI. Our study results show that a greater proportion of African Americans experience persistent moderate or severe pain. This finding is consistent with data that African Americans experience worse pain outcomes after other types of trauma/stress exposure (eg, bone fracture, postsurgical). 17, 34, 60, 63 These data are also consistent with evidence that African Americans experience increased pain sensitivity in experimental settings. 7, 26, 48 At 6 weeks, the model estimate of 1.21 (95% confidence interval [0.12-2.29]) represents a 46% (1.21/2.6) difference in NRS (African Americans have an average pain NRS of 2.6 at 6 weeks), which is clinically meaningful based on our cutoff of 15%, but this result does not reach statistical significance after adjusting for multiple comparisons. Our finding that African Americans experience an increased burden of itch after MThBI is consistent with data that African Americans experience an increased burden of itch in conditions in which itch is prevalent (eg, primary biliary cirrhosis 46 and eczema 52 ). If confirmed by future studies, an increased burden of pain and itch experienced by African American MThBI survivors is of particular importance as African Americans are at higher risk of MThBI. 
Limitations
Several limitations should be considered when interpreting our study results. First, our sample size (n 5 96) was small and included 39 African Americans, 43 European Americans at the 6-month followup. However, unlike many previous studies of this difficult to recruit population, our follow-up rates were excellent, increasing internal validity. 32, 38 In addition, no studies have examined ethnic differences in pain or itch outcomes among MThBI survivors. Further prospective studies are needed to reproduce/confirm our findings, given the small sample size. Second, our study was limited to only patients who presented to major burn centers. However, the majority of MThBI survivors receiving tissue autograft are treated at such centers. 4 Another potential limitation is the influence of periassessment activities (occupational therapy, dressing changes, etc.) on pain or itch reporting. However, the effect of these activities would be random, increasing noise, and biasing findings toward the null. Our study evaluated the class of medication that was prescribed for each patient; however, analgesic consumptions were not quantitatively reported. In future studies, this would allow the contribution of analgesic consumption on persistent pain and itch pathogenesis to be further evaluated. Another limitation is that the ethnicity of the interviewer/assessor, which may potentially confound the results, was not recorded. Although racial concordance was not found to influence pain reporting in experimental pain conditions, 62 future studies quantifying the effect of assessor ethnicity of pain reporting are needed. Finally, our study included only 1 common population of burn patients. Other studies are needed which evaluate pain and itch outcome disparities in other burn populations (eg, pediatric populations, those with electrical or chemical burns).
Conclusions
In this prospective study of patients with MThBI receiving tissue autograft, African Americans experienced significant, clinically relevant increases in pain and itch severity outcomes in comparison with European Americans. These differences were not explained by differences in baseline mental health or whether individuals reported taking an opioid. Future studies evaluating differences in pain and itch outcomes between African Americans and European Americans experiencing MThBI may both improve outcomes in African American patients and lead to new pathogenic insights that benefit all burn injury survivors.
